CoChat

Multivalent Carbohydrate-Lectin Interactions: How Synthetic Chemistry Enables Insights into Nanometric Recognition

Open access

The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.

Abstract

Glycan recognition by sugar receptors (lectins) is intimately involved in many aspects of cell physiology. However, the factors explaining the exquisite selectivity of their functional pairing are not yet fully understood. Studies toward this aim will also help appraise the potential for lectin-directed drug design. With the network of adhesion/growth-regulatory galectins as therapeutic targets, the strategy to recruit synthetic chemistry to systematically elucidate structure-activity relationships is outlined, from monovalent compounds to glyco-clusters and glycodendrimers to biomimetic surfaces. The versatility of the synthetic procedures enables to take examining structural and spatial parameters, alone and in combination, to its limits, for example with the aim to produce inhibitors for distinct galectin(s) that exhibit minimal reactivity to other members of this group. Shaping spatial architectures similar to glycoconjugate aggregates, microdomains or vesicles provides attractive tools to disclose the often still hidden significance of nanometric aspects of the different modes of lectin design (sequence divergence at the lectin site, differences of spatial type of lectin-site presentation). Of note, testing the effectors alone or in combination simulating (patho)physiological conditions, is sure to bring about new insights into the cooperation between lectins and the regulation of their activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules21050629

Cites

138 of 138 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Illustration of the alphabet of the sugar language. Structural representation, name and symbol as well as the set of known acceptor positions (arrows) in glycoconjugates are given for each letter. Four sugars have l-configuration: fucose (6-deoxy-l-galactose), rhamnose (6-deoxy-l-mannose) and arabinose are introduced during chain elongation, whereas l-iduronic acid (IdoA) results from post-synthetic epimerization of glucuronic acid at C-5. The 1C4 conformation of IdoA (a) is in equilibrium with the 2S0 form (b) in glycosaminoglycan chains, where this uronic acid can be 2-sulfated. All other letters are d-sugars. Neu5Ac, one of the more than 50 sialic acids, often terminates sugar chains in animal glycoconjugates. Kdo is a constituent of lipopolysaccharides in the cell walls of Gram-negative bacteria and is also found in cell wall polysaccharides of green algae and higher plants. Foreign to mammalian glycobiochemistry, microbial polysaccharides contain the furanose ring form of d-galactose and also d/l-arabinose, then indicated by an italic “f” derived from the heterocyclus furan. The α-anomer is prevalent for the pentose arabinose, e.g., in mycobacterial cell wall arabinogalactan and lipoarabinomannan. β1-5/6-Linked galactofuranoside is present in the arabinogalactan and the α1-3/6 linkage in lipopolysaccharides (adapted from [15]).
Figure 1 Illustration of the alphabet of the sugar language. Structural representation, name and symbol as well as the set of known acceptor positions (arrows) in glycoconjugates are given for each letter. Four sugars have l-configuration: fucose (6-deoxy-l-galactose), rhamnose (6-deoxy-l-mannose) and arabinose are introduced during chain elongation, whereas l-iduronic acid (IdoA) results from post-synthetic epimerization of glucuronic acid at C-5. The 1C4 conformation of IdoA (a) is in equilibrium with the 2S0 form (b) in glycosaminoglycan chains, where this uronic acid can be 2-sulfated. All other letters are d-sugars. Neu5Ac, one of the more than 50 sialic acids, often terminates sugar chains in animal glycoconjugates. Kdo is a constituent of lipopolysaccharides in the cell walls of Gram-negative bacteria and is also found in cell wall polysaccharides of green algae and higher plants. Foreign to mammalian glycobiochemistry, microbial polysaccharides contain the furanose ring form of d-galactose and also d/l-arabinose, then indicated by an italic “f” derived from the heterocyclus furan. The α-anomer is prevalent for the pentose arabinose, e.g., in mycobacterial cell wall arabinogalactan and lipoarabinomannan. β1-5/6-Linked galactofuranoside is present in the arabinogalactan and the α1-3/6 linkage in lipopolysaccharides (adapted from [15]).CC BY · PubMed Central
Figure 2 Illustration of the strategic ways that carbohydrate recognition domains (CRDs) in animal lectins are positioned to reach optimal ligand selection (for example, to separate self from non-self glycan profiles in innate immunity) and topological complementarity. From left to right, the CRD display in the three subtypes within the galectin family (chimera-type (a); proto-type (b) and tandem-repeat-type (c) arrangements binding to the saccharide portion of a ganglioside or a branched complex-type N-glycan without or with terminal α2,3-sialylation; please see also Figure 3), the presentation of CRDs (C-type or fibrinogen-like domain) in serum and surfactant collectins or ficolins (d) connected to their collagenous stalks and the non-covalent association of binding sites in transmembrane C-type lectins by α-helical coiled-coil stalks (e) (for example asialoglycoprotein and Kupffer cell receptors, the scavenger receptor C-type lectin, CD23, DC-SIGN or DC-SIGNR) are given. Similar to tandem-repeat-type galectins, the C-type family of lectins also has a branch of members with this design, i.e., immulectins-1, -2 and -3. Next, the tandem-repeat display in the mannose-specific macrophage receptor (f) (also found on dendritic cells, hepatic endothelial cells, kidney mesangial cells, retinal pigment epithelial cells and tracheal smooth muscle cells) and the related C-type lectin Endo180 with eight domains as well as in the cation-independent P-type lectin with 15 domains is presented. Capacity for sugar binding is confined to only few domains as depicted. The occurrence of lectin activity for GalNAc-4-SO4-bearing pituitary glycoprotein hormones in the cysteine-rich domain, a member of the β-trefoil fold family with one (QxW)3 domain in the N-terminal section of the macrophage mannose receptor (amino acids 8–128), which is linked via a fibronectin-type-II-repeat-containing module to the tandem-repeat section, is also included into the schematic drawing for these lectins with more than one type of CRD per protein chain. Moving further to the right side; (g) the association of a distal CRD in selectins (attached to an epidermal-growth-factor (EGF)-like domain and two to nine complement-binding consensus repeats) or in the siglec subfamily of I-type lectins using 1–16 C2-set immunoglobulin-like units as spacer equivalents to let the CRD reach out to contact ligands and to modulate capacity to serve in cis- or trans-interactions on the cell surface is shown. The force-dependent alterations of the topological arrangement of the two distal domains in selectins accounts for catch bonds of selectins, a canonical immunoreceptor tyrosine-based inhibitory motif (ITIM) together with a putative tyrosine-based motif is frequently present in the intracellular portion of siglecs. C2-set domains linked to fibronectin-type-III repeats establish the extracellular section of the I-type lectins L1 and neural cell adhesion molecule (NCAM) (h). In the matrix, the modular proteoglycans (i) (hyalectans/lecticans: aggrecan, brevican, neurocan and versican) interact (i) with hyaluronan (and also link protein) via the link-protein-type modules of the N-terminal G1 domain (and an Ig-like module); (ii) with receptors binding to the glycosaminoglycan chains in the central region and (iii) with carbohydrates or proteins (fibulins-1 and -2 and tenascin-R) via the C-type lectin-like domain flanked by EGF-like and complement-binding consensus repeat modules (kindly provided by H. Kaltner) (from [38], with permission).
Figure 2 Illustration of the strategic ways that carbohydrate recognition domains (CRDs) in animal lectins are positioned to reach optimal ligand selection (for example, to separate self from non-self glycan profiles in innate immunity) and topological complementarity. From left to right, the CRD display in the three subtypes within the galectin family (chimera-type (a); proto-type (b) and tandem-repeat-type (c) arrangements binding to the saccharide portion of a ganglioside or a branched complex-type N-glycan without or with terminal α2,3-sialylation; please see also Figure 3), the presentation of CRDs (C-type or fibrinogen-like domain) in serum and surfactant collectins or ficolins (d) connected to their collagenous stalks and the non-covalent association of binding sites in transmembrane C-type lectins by α-helical coiled-coil stalks (e) (for example asialoglycoprotein and Kupffer cell receptors, the scavenger receptor C-type lectin, CD23, DC-SIGN or DC-SIGNR) are given. Similar to tandem-repeat-type galectins, the C-type family of lectins also has a branch of members with this design, i.e., immulectins-1, -2 and -3. Next, the tandem-repeat display in the mannose-specific macrophage receptor (f) (also found on dendritic cells, hepatic endothelial cells, kidney mesangial cells, retinal pigment epithelial cells and tracheal smooth muscle cells) and the related C-type lectin Endo180 with eight domains as well as in the cation-independent P-type lectin with 15 domains is presented. Capacity for sugar binding is confined to only few domains as depicted. The occurrence of lectin activity for GalNAc-4-SO4-bearing pituitary glycoprotein hormones in the cysteine-rich domain, a member of the β-trefoil fold family with one (QxW)3 domain in the N-terminal section of the macrophage mannose receptor (amino acids 8–128), which is linked via a fibronectin-type-II-repeat-containing module to the tandem-repeat section, is also included into the schematic drawing for these lectins with more than one type of CRD per protein chain. Moving further to the right side; (g) the association of a distal CRD in selectins (attached to an epidermal-growth-factor (EGF)-like domain and two to nine complement-binding consensus repeats) or in the siglec subfamily of I-type lectins using 1–16 C2-set immunoglobulin-like units as spacer equivalents to let the CRD reach out to contact ligands and to modulate capacity to serve in cis- or trans-interactions on the cell surface is shown. The force-dependent alterations of the topological arrangement of the two distal domains in selectins accounts for catch bonds of selectins, a canonical immunoreceptor tyrosine-based inhibitory motif (ITIM) together with a putative tyrosine-based motif is frequently present in the intracellular portion of siglecs. C2-set domains linked to fibronectin-type-III repeats establish the extracellular section of the I-type lectins L1 and neural cell adhesion molecule (NCAM) (h). In the matrix, the modular proteoglycans (i) (hyalectans/lecticans: aggrecan, brevican, neurocan and versican) interact (i) with hyaluronan (and also link protein) via the link-protein-type modules of the N-terminal G1 domain (and an Ig-like module); (ii) with receptors binding to the glycosaminoglycan chains in the central region and (iii) with carbohydrates or proteins (fibulins-1 and -2 and tenascin-R) via the C-type lectin-like domain flanked by EGF-like and complement-binding consensus repeat modules (kindly provided by H. Kaltner) (from [38], with permission).CC BY · PubMed Central
Figure 3 The three basic types of modular design of galectins, as given in the context of other lectins in Figure 2. Proto-type proteins (e.g., galectins-1, -2 and -7) are non-covalently associated homodimers, the vertebrate tandem-repeat-type galectins are formed by two different CRDs connected by a linker (length can vary by alternative splicing and between species) and the chimera-type galectin-3 has an N-terminal tail composed of a peptide with site(s) for Ser phosphorylation and Gly/Pro-rich sequence repeats enabling self-association in the presence of multivalent ligands.
Figure 3 The three basic types of modular design of galectins, as given in the context of other lectins in Figure 2. Proto-type proteins (e.g., galectins-1, -2 and -7) are non-covalently associated homodimers, the vertebrate tandem-repeat-type galectins are formed by two different CRDs connected by a linker (length can vary by alternative splicing and between species) and the chimera-type galectin-3 has an N-terminal tail composed of a peptide with site(s) for Ser phosphorylation and Gly/Pro-rich sequence repeats enabling self-association in the presence of multivalent ligands.CC BY · PubMed Central
Figure 4 Canonical galectins (according to the classification given in Figure 2) in model organisms on the level of gene (Roman number), transcript (Arabic number) and protein (numerical information). For details, please see [42,43].
Figure 4 Canonical galectins (according to the classification given in Figure 2) in model organisms on the level of gene (Roman number), transcript (Arabic number) and protein (numerical information). For details, please see [42,43].CC BY · PubMed Central
Figure 5 Sequence of steps to identify high-affinity carbohydrate ligands for galectin binding. Galectin interaction with the most potent binders based on this screening can then be studied further on the structural level.
Figure 5 Sequence of steps to identify high-affinity carbohydrate ligands for galectin binding. Galectin interaction with the most potent binders based on this screening can then be studied further on the structural level.CC BY · PubMed Central
Figure 6 Representative structures of galectin ligands.
Figure 6 Representative structures of galectin ligands.CC BY · PubMed Central
Figure 7 Comparison of structures of LNF-III (left) and 3′-sulfated lactose derivatives (right) that bind almost equally well to human galectin-8N. Suggested additional modifications of the sugar head groups together with their substituents, which might increase the affinity of glycans toward galectins, while limiting synthetic efforts towards this achievement, are highlighted.
Figure 7 Comparison of structures of LNF-III (left) and 3′-sulfated lactose derivatives (right) that bind almost equally well to human galectin-8N. Suggested additional modifications of the sugar head groups together with their substituents, which might increase the affinity of glycans toward galectins, while limiting synthetic efforts towards this achievement, are highlighted.CC BY · PubMed Central
Figure 8 Human galectin-8N (Connolly surfaces and binding sites) loaded with lacto-N-fucopentaose-III (top) and 3′-sulfated lactose (bottom) (PDB 3AP9).
Figure 8 Human galectin-8N (Connolly surfaces and binding sites) loaded with lacto-N-fucopentaose-III (top) and 3′-sulfated lactose (bottom) (PDB 3AP9).CC BY · PubMed Central
Figure 9 Relative spatial orientation of CRDs of galectins, which can be differently responsible for intra/inter-cellular cross-linking (left: face view; right: lateral view). Blue arrows point the positioning of two CRDs.
Figure 9 Relative spatial orientation of CRDs of galectins, which can be differently responsible for intra/inter-cellular cross-linking (left: face view; right: lateral view). Blue arrows point the positioning of two CRDs.CC BY · PubMed Central
Scheme 1 Synthetic strategy leading to O- or S-lactosides under phase transfer-catalyzed (PTC) conditions.
Scheme 1 Synthetic strategy leading to O- or S-lactosides under phase transfer-catalyzed (PTC) conditions.CC BY · PubMed Central
Scheme 2 Representative synthesis of regioselectively 4-substituted 1,2,3-triazole lactoside 6 using copper-catalyzed azide–alkyne cycloaddition (CuAAC, click chemistry).
Scheme 2 Representative synthesis of regioselectively 4-substituted 1,2,3-triazole lactoside 6 using copper-catalyzed azide–alkyne cycloaddition (CuAAC, click chemistry).CC BY · PubMed Central
Scheme 3 Structures of O-digalactoside (ODG) and its S- and Se- mimics (TDG and SeDG), with synthesis of SeDG.
Scheme 3 Structures of O-digalactoside (ODG) and its S- and Se- mimics (TDG and SeDG), with synthesis of SeDG.CC BY · PubMed Central
Scheme 4 Example of oligosaccharide synthesis to produce naturally occurring galectin ligands.
Scheme 4 Example of oligosaccharide synthesis to produce naturally occurring galectin ligands.CC BY · PubMed Central
Scheme 5 Chemical modifications of lactosides at both the aglycones and at the 3′-position.
Scheme 5 Chemical modifications of lactosides at both the aglycones and at the 3′-position.CC BY · PubMed Central
Figure 10 Schematic representation of the CRD site of human galectin-3 (PDB 3AYE) showing all amino acids involved as per Table 1 and interacting with compound 17 (docked in by superposition with natural lactose ligand); left Connolly surface representation with red surface (anionic) and blue surface (cationic amino acids).
Figure 10 Schematic representation of the CRD site of human galectin-3 (PDB 3AYE) showing all amino acids involved as per Table 1 and interacting with compound 17 (docked in by superposition with natural lactose ligand); left Connolly surface representation with red surface (anionic) and blue surface (cationic amino acids).CC BY · PubMed Central
Scheme 6 Structures of bivalent glycoclusters based on glycophane and an acyclic variant. Space-filling model of 26 is shown on right with distance between galactose anomeric carbon atoms indicated.
Scheme 6 Structures of bivalent glycoclusters based on glycophane and an acyclic variant. Space-filling model of 26 is shown on right with distance between galactose anomeric carbon atoms indicated.CC BY · PubMed Central
Scheme 7 A panel of synthetic lactose-presenting bivalent compounds with inter-galactoside distances are shown. Various types of scaffolds have been used including secondary and tertiary diamides, diglycosyldiamides, ditriazoles and glycophanes.
Scheme 7 A panel of synthetic lactose-presenting bivalent compounds with inter-galactoside distances are shown. Various types of scaffolds have been used including secondary and tertiary diamides, diglycosyldiamides, ditriazoles and glycophanes.CC BY · PubMed Central
Scheme 8 Synthesis of glycophane 26 and the acyclic analogue 25.
Scheme 8 Synthesis of glycophane 26 and the acyclic analogue 25.CC BY · PubMed Central
Scheme 9 Synthesis of glycophane 36 and the acyclic analogue 35.
Scheme 9 Synthesis of glycophane 36 and the acyclic analogue 35.CC BY · PubMed Central
Scheme 10 Synthesis of diamides with the histo-blood H trisaccharide headgroup.
Scheme 10 Synthesis of diamides with the histo-blood H trisaccharide headgroup.CC BY · PubMed Central
Scheme 11 Synthesis of the bivalent compound 53.
Scheme 11 Synthesis of the bivalent compound 53.CC BY · PubMed Central
Scheme 12 Trivalent lactose-presenting cluster 56 with equivalent inter-galactoside distances was obtained using the core 54 and 2-propynyl lactoside 55. It showed remarkable reactivity with galectin-3 [111].
Scheme 12 Trivalent lactose-presenting cluster 56 with equivalent inter-galactoside distances was obtained using the core 54 and 2-propynyl lactoside 55. It showed remarkable reactivity with galectin-3 [111].CC BY · PubMed Central
Scheme 13 Tetrameric lactoside clusters 59 and 60 with different inter-galactoside distances prepared using palladium-catalyzed cross coupling Sonogashira reactions.
Scheme 13 Tetrameric lactoside clusters 59 and 60 with different inter-galactoside distances prepared using palladium-catalyzed cross coupling Sonogashira reactions.CC BY · PubMed Central
Scheme 14 Trivalent 2′-fucosyl lactose-presenting cluster 62 prepared using click-chemistry reaction from 51 and phloroglucinol derivative. In this case, inter-galactoside distances are shorter than in 56.
Scheme 14 Trivalent 2′-fucosyl lactose-presenting cluster 62 prepared using click-chemistry reaction from 51 and phloroglucinol derivative. In this case, inter-galactoside distances are shorter than in 56.CC BY · PubMed Central
Scheme 15 Poly(amidoamine) dendrimer of generation G2 (65) incorporating 16 lactoside residues linked through thiourea linkages.
Scheme 15 Poly(amidoamine) dendrimer of generation G2 (65) incorporating 16 lactoside residues linked through thiourea linkages.CC BY · PubMed Central
Scheme 16 Synthetic procedures leading to hexaphenylbenzene core (69) which was either directly propargylated to give 70 or treated with a propargylated TRIS intermediate (71) to afford a scaffold harboring 18-propargyl residues (72).
Scheme 16 Synthetic procedures leading to hexaphenylbenzene core (69) which was either directly propargylated to give 70 or treated with a propargylated TRIS intermediate (71) to afford a scaffold harboring 18-propargyl residues (72).CC BY · PubMed Central
Scheme 17 Accelerated synthesis of multivalent lactosides using click chemistry with scaffold 72 and a lactosyl azide (4) to give a glycodendrimer with 18-exposed lactoside residues.
Scheme 17 Accelerated synthesis of multivalent lactosides using click chemistry with scaffold 72 and a lactosyl azide (4) to give a glycodendrimer with 18-exposed lactoside residues.CC BY · PubMed Central
Scheme 18 Lactose-presenting glycoclusters with an azide functionality at the focal point were used for the convergent synthesis of highly substituted glycodendrimers 79 (3-mer), 80 (5-mer), and 83 (10-mer) possessing an extended tetraethylene glycol spacer for accessibility to galectins.
Scheme 18 Lactose-presenting glycoclusters with an azide functionality at the focal point were used for the convergent synthesis of highly substituted glycodendrimers 79 (3-mer), 80 (5-mer), and 83 (10-mer) possessing an extended tetraethylene glycol spacer for accessibility to galectins.CC BY · PubMed Central
Scheme 19 Convergent synthesis of a globular glycodendrimer with six (6-mer, 87), eighteen (18-mer, 88), and thirty six (30-mer, 90) sugar headgroups.
Scheme 19 Convergent synthesis of a globular glycodendrimer with six (6-mer, 87), eighteen (18-mer, 88), and thirty six (30-mer, 90) sugar headgroups.CC BY · PubMed Central
Scheme 20 Illustration of the structures of variations of the theme to build glycodendrimers with the same core as in Scheme 18 harboring 20 (91), 30 (92), 60 (93), and 90 (94) lactoside residues.
Scheme 20 Illustration of the structures of variations of the theme to build glycodendrimers with the same core as in Scheme 18 harboring 20 (91), 30 (92), 60 (93), and 90 (94) lactoside residues.CC BY · PubMed Central
Scheme 21 Typical structure of a natural glycolipid (LacCer) compared to a member of the recently synthesized family of self-assembling amphiphilic Janus glycodendrimers capable of forming stable liposomes (glycodendrimersomes).
Scheme 21 Typical structure of a natural glycolipid (LacCer) compared to a member of the recently synthesized family of self-assembling amphiphilic Janus glycodendrimers capable of forming stable liposomes (glycodendrimersomes).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 13

  1. Sharon, N. (1975). Complex Carbohydrates. Their Chemistry, Biosynthesis, and Functions, Addison-Wesley Publ. Co.
  2. Gabius, H.-J. (2009). The Sugar Code: Fundamentals of Glycosciences, Wiley-VCH.
  3. Gabius, H.-J. (2009). The Sugar Code. Fundamentals of Glycosciences, Wiley-VCH.
  4. Gabius, H.-J. (2009). The Sugar Code: Fundamentals of Glycosciences, Wiley-VCH.
  5. Gabius, H.-J. (2009). The Sugar Code: Fundamentals of Glycosciences, Wiley-VCH.
  6. Gabius, H.-J. (2009). The Sugar Code: Fundamentals of Glycosciences, Wiley-VCH.
  7. Gabius, H.-J. (2009). The Sugar Code: Fundamentals of Glycosciences, Wiley-VCH.
  8. Montreuil, J., Vliegenthart, J.F.G., and Schachter, H. (1995). Glycoproteins, Elsevier.
  9. Gabius, H.-J. (2009). The Sugar Code: Fundamentals of Glycosciences, Wiley-VCH.
  10. Gabius, H.-J. (2009). The Sugar Code: Fundamentals of Glycosciences, Wiley-VCH.
  11. Gabius, H.-J. (2009). The Sugar Code: Fundamentals of Glycosciences, Wiley-VCH.
  12. Lee, Y.C., and Lee, R.T. (1994). Neoglycoconjugates, Preparation and Applications, Academic Press.
  13. Gabius, H.-J. (2009). The Sugar Code: Fundamentals of Glycosciences, Wiley-VCH.

Cited by

See all 77

Metadata

Authors
Roy, R., Murphy, P., & Gabius, H.-J.
Affiliations
  • Université du Québec à Montréal (CA)
  • Ollscoil na Gaillimhe – University of Galway (IE)
  • Ludwig-Maximilians-Universität München (DE)
Corresponding author
Roy, René
Venue
Molecules
Publisher
MDPI AG
Published
2016-05-13
Volume
21
Issue
5
Pages
629
ISSN
1420-3049 (ISSN-L)
OpenAlex
W2371954262
Cited by
76
References
138
Citations by year
2026: 5 · 2025: 5 · 2024: 3 · 2023: 8 · 2022: 6 · 2021: 7 · 2020: 6 · 2019: 4 · 2018: 10 · 2017: 12 · 2016: 10
FWCI
0.59
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) (acceptedVersion, cc-by-nc-nd)
  • ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) (submittedVersion, cc-by-nc-nd)
  • Arrow@dit (Dublin Institute of Technology) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion)
  • Research Repository UCD (University College Dublin)
Funders
  • European Commission
  • Science Foundation Ireland (12/IA/1398, 08/SRC/B1393)
  • Natural Sciences and Engineering Research Council of Canada
  • European Regional Development Fund (14/SP/2710)
  • Canadian Glycomics Network
Topics
  • Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
  • Life Sciences › Immunology and Microbiology › Immunology › Galectins and Cancer Biology
Keywords
galectins, structure-activity relationship, galectin inhibitors, glycodendrimers, biomimetic surfaces, vesicles
MeSH terms
Carbohydrates, Glycoproteins, Humans, Models, Molecular, Polysaccharides, Structure-Activity Relationship, Galectins, Dendrimers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.